Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

By J. You, D. Singer, P. Howard, D. Lane, M. Eckman, M. Fang, E. Hylek, S. Schulman, Alan S. Go, M. Hughes and 4 more. Chest, 2012

995 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine

View Paper: https://www.semanticscholar.org/paper/cdd11590efaf5c8899da4c97f712e6cd97840c4b

Citations in the corpus

• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, neutral): “Thromboembolism prevention With AF or atrial flutter for ≥48 h, or unknown duration, anticoagulate with warfarin for at least 3 wk prior to and 4 wk after cardioversion I B (110-113)”